← All medicines
Onglyza 2.5 mg film-coated tablets
Licence EU/1/09/545/011-015 · Unknown
- Licence holder
- AstraZeneca AB (all products →)
- Active substance
- Saxaglitpin
- Dosage form
- Film-coated tablet
- Route of administration
- Oral use
- ATC codes
- A10BH, A10BH03
- First authorised
- 28/02/2011
- Prescription status
- Product subject to prescription which may be renewed (B)
- Supply
- Supply through pharmacies only
- Legal basis
- New active substance (Article 8(3) of Directive No 2001/83/EC)
Data: Health Products Regulatory Authority (HPRA) open dataset, licensed CC BY 4.0, published 04 Jul 2026. This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.